Biogen shares jump on plans to move into late-stage trials of Alzheimer's drug

December 2, 2014 3:43 PM

3 0

Biogen shares jump on plans to move into late-stage trials of Alzheimer's drug

Biogen Idec this morning reported promising news from an early-stage trial of its drug to treat Alzheimer's, a disease which threatens to weigh heavily on healthcare costs worldwide in coming years.

The Cambridge biotech's shares shot up as high as 9 percent this morning before settling back down to about $325 a share, up 5 percent from Monday's close, based on the news.

Read more

To category page

Loading...